$ Value
$0
Shares
28,560
Price
$0
Filed
Apr 29
Insider
Name
Newton Charles W.
Title
—
CIK
0001866219
Roles
Transaction Details
Transaction Date
2025-04-25
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
28,560
Footnotes
The shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the April 25, 2025 grant date (the "Grant Date"), in each case subject to continued service on the Company's Board of Directors through such vesting date. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock. | The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.
Filing Info
Newton Charles W.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-08-21 | LYEL | ▼ | $15K |
| 2025-08-20 | LYEL | A | $0 |
| 2025-08-12 | LYEL | ▼ | $1K |
| 2025-08-11 | LYEL | ▼ | $1K |
| 2025-06-12 | CHRS | A | $0 |
| 2025-05-13 | TSVT | D | — |
| 2025-05-13 | TSVT | U | — |
| 2025-05-13 | TSVT | D | — |
| 2025-05-13 | TSVT | D | — |
| 2025-04-25 | NVAX | A | $0 |
Other Insiders at NVAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Casey Mark J
EVP, Chief Legal Officer
|
— | — | 2026-03-03 |
|
Kelly James Patrick
EVP, CFO and Treasurer
|
— | — | 2026-03-07 |
|
Jacobs John C
President and CEO
|
— | — | 2026-03-03 |
|
O'Hara Elaine
EVP, Chief Strategy Officer
|
— | — | 2026-03-03 |
|
Draghia-Akli Ruxandra
EVP, Research & Development
|
— | — | 2026-03-03 |
|
Walker Robert Edward
EVP, R&D
|
— | — | 2026-04-14 |